Loading organizations...
Loading organizations...
Biopharmaceuticals company developing cancer and immune disorder therapies.
Gliknik has raised $32.5M across 5 funding rounds.
Gliknik has raised $32.5M in total across 5 funding rounds.
Gliknik has raised $32.5M in total across 5 funding rounds.
Gliknik's investors include Kyle Rusconi, Garden Street Holdings, RDA Ventures, SAISO Partners, Norbert Rieidel, Joel Braunstein, MD.
Gliknik has raised $32.5M across 5 funding rounds. Most recently, it raised $11.5M Series C in June 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 24, 2021 | $11.5M Series C | Kyle Rusconi | Garden Street Holdings, RDA Ventures, SAISO Partners |
| Sep 18, 2013 | $2.8M Other Equity | ||
| May 1, 2013 | $9.8M Other Equity | ||
| Oct 8, 2012 | $4.9M Series B | Norbert Rieidel | |
| Jan 6, 2011 | $3.5M Other Equity | Joel Braunstein, MD |